Maxalt
NDC 21695-956
Product Information
Maxalt is a NDA-approved product labeled by Rebel Distributors Corp. Rizatriptan is used to treat migraines. It is supplied as a pink product. This product entry covers the primary NDC 21695-956 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
MAXALT;MRK;267
Code Structure Chart
Product Details
What is NDC 21695-956?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RIZATRIPTAN BENZOATE (UNII: WR978S7QHH)
- RIZATRIPTAN (UNII: 51086HBW8G) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- STARCH, CORN (UNII: O8232NY3SJ)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 213322 - Maxalt 10 MG Oral Tablet
- RxCUI: 213322 - rizatriptan 10 MG Oral Tablet [Maxalt]
- RxCUI: 314209 - rizatriptan benzoate 10 MG Oral Tablet
- RxCUI: 314209 - rizatriptan 10 MG Oral Tablet
- RxCUI: 314209 - rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Oral Tablet
* Please review the full disclaimer at the bottom of this page.